Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/34324
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2023-10-12T11:01:15Z-
dc.date.available2023-10-12T11:01:15Z-
dc.date.issued2020-
dc.identifier.citationSarandöl, E. vd. (2020). "Effects of thiamine treatment on oxidative stress in experimental diabetes". Bratislava Medical Journal, 121(3), 235-241en_US
dc.identifier.issn00069248-
dc.identifier.issn1336-0345-
dc.identifier.urihttps://doi.org/10.4149/BLL_2020_036-
dc.identifier.urihttp://www.elis.sk/download_file.php?product_id=6606&session_id=dgnvno7rlck9lu3lojrempasf4-
dc.identifier.urihttp://hdl.handle.net/11452/34324-
dc.description.abstractAIM: Hyperglycemia, oxidative stress and hyperlipidemia are features of diabetes mellitus. Thiamine has beneficial effects on carbohydrate metabolism and it was proposed that this vitamin has antihyperlipidemic and antioxidant effects. Our aim was to investigate the effects of thiamine on oxidative stress and metabolic changes in streptozotocin (STZ) induced diabetic rats. METHOD: Diabetes was induced by a single intraperitoneal injection of STZ. Thiamine (6 mg/kg) was added to drinking water for five weeks. The rats were divided into four groups: control rats; thiamine treated control rats; diabetic rats; thiamine treated diabetic rats. Plasma and tissue malondialdehyde (MDA) levels were measured by high-performance liquid chromatography and spectrophotometry, respectively. Paraoxonase (PON) and arylesterase (AE) activities were measured with spectrophotometric methods, and erythrocyte superoxide dismutase (SOD) and blood glutathione peroxidase (GSH-Px) activities were determined using commercial kits. RESULTS: Thiamine treatment reduced plasma and tissue MDA levels, serum glucose, total cholesterol and triglyceride levels, and increased serum high density lipoprotein-cholesterol and insulin levels, serum PON and AE, erythrocyte SOD and blood GSH-Px activities. CONCLUSION: Thiamine significantly improves oxidative stress and has hyperinsulinemic and antihyperlipidemic effects so we suggest that thiamine might be used as a supportive therapeutic agent in diabetes (Tab. 2, Fig. 3, Ref. 53).en_US
dc.language.isoenen_US
dc.publisherAepress Sroen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectGeneral & internal medicineen_US
dc.subjectStreptozotocinen_US
dc.subjectThiamineen_US
dc.subjectOxidative stressen_US
dc.subjectParaoxonaseen_US
dc.subjectHuman-serum paraoxonaseen_US
dc.subjectPhosphate-estersen_US
dc.subjectVanadyl sulfateen_US
dc.subjectPlasmaen_US
dc.subjectArylesteraseen_US
dc.subjectMetabolismen_US
dc.subjectComplicationsen_US
dc.subjectDyslipidemiaen_US
dc.subjectGlycationen_US
dc.subjectTransporten_US
dc.subjectDiabetes mellitusen_US
dc.subject.meshAnimalsen_US
dc.subject.meshAntioxidantsen_US
dc.subject.meshBlood glucoseen_US
dc.subject.meshDiabetes mellitus, experimentalen_US
dc.subject.meshMalondialdehydeen_US
dc.subject.meshOxidative stressen_US
dc.subject.meshRatsen_US
dc.subject.meshRats, wistaren_US
dc.subject.meshSuperoxide dismutaseen_US
dc.subject.meshThiamineen_US
dc.titleEffects of thiamine treatment on oxidative stress in experimental diabetesen_US
dc.typeArticleen_US
dc.identifier.wos000528258200011tr_TR
dc.identifier.scopus2-s2.0-85080839972tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi Fakültesi/Temel Tıp Bilimleri Bölümü.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Fen Edebiyat Fakültesi/Biyoloji Bölümü.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı.tr_TR
dc.contributor.orcidABE-1716-2020tr_TR
dc.contributor.orcidABE-6873-2020tr_TR
dc.contributor.orcidAAH-6200-2021tr_TR
dc.contributor.orcidESK-6562-2022tr_TR
dc.identifier.startpage235tr_TR
dc.identifier.endpage241tr_TR
dc.identifier.volume121tr_TR
dc.identifier.issue3tr_TR
dc.relation.journalBratislava Medical Journalen_US
dc.contributor.buuauthorSarandöl, Emre-
dc.contributor.buuauthorTaş, Sibel-
dc.contributor.buuauthorSerdar, Zehra-
dc.contributor.buuauthorDirican, Melahat-
dc.contributor.researcherid0000-0002-2593-7196tr_TR
dc.contributor.researcherid0000-0002-0909-618Xtr_TR
dc.identifier.pubmed32115983tr_TR
dc.subject.wosMedicine, general & internalen_US
dc.indexed.wosSCIEen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ3en_US
dc.contributor.scopusid55943324800tr_TR
dc.contributor.scopusid7004343411tr_TR
dc.contributor.scopusid57222002284tr_TR
dc.contributor.scopusid6601919847tr_TR
dc.subject.scopusExtract; Dimethylbenz[A]Anthracene; Nutsen_US
dc.subject.emtreeAntioxidanten_US
dc.subject.emtreeMalonaldehydeen_US
dc.subject.emtreeSuperoxide dismutaseen_US
dc.subject.emtreeThiamineen_US
dc.subject.emtreeAnimalen_US
dc.subject.emtreeDrug effecten_US
dc.subject.emtreeExperimental diabetes mellitusen_US
dc.subject.emtreeGlucose blood levelen_US
dc.subject.emtreeOxidative stressen_US
dc.subject.emtreeRaten_US
dc.subject.emtreeWistar raten_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Sarandöl_vd_2020.pdf224.67 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons